Study of PEG-Intron Plus REBETOL in Pediatric Subjects With Chronic Hepatitis C (Study P02538 Part 1)
Status:
Completed
Trial end date:
2007-11-01
Target enrollment:
Participant gender:
Summary
The primary objective is to assess the safety, efficacy and tolerability of the combination
of PEG-Intron plus REBETOL in pediatric subjects with chronic hepatitis C. The secondary
objective is to measure the multiple-dose pharmacokinetics of PEG-Intron and REBETOL in
pediatric subjects with chronic hepatitis C.